1. Home
  2. ZJYL vs KALA Comparison

ZJYL vs KALA Comparison

Compare ZJYL & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$2.01

Market Cap

292.7M

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.16

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
KALA
Founded
2006
2009
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.7M
319.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
ZJYL
KALA
Price
$2.01
$0.16
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
214.4K
8.0M
Earning Date
08-20-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.50
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.15
52 Week High
$2.86
$20.58

Technical Indicators

Market Signals
Indicator
ZJYL
KALA
Relative Strength Index (RSI) 70.71 26.81
Support Level $0.57 N/A
Resistance Level $2.86 $0.72
Average True Range (ATR) 0.20 0.02
MACD -0.03 0.00
Stochastic Oscillator 49.09 19.48

Price Performance

Historical Comparison
ZJYL
KALA

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: